Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 12, 2005, Pages 1042-1048

  Ye, Jian ^a   Li, Aiping ^a   Liu, Qizhan ^a   Wang, Xinru ^a   Zhou, Jianwei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Arsenic trioxide; MCF 7; Mitogen activated protein kinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ARSENIC TRIOXIDE; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPIDIUM IODIDE; STRESS ACTIVATED PROTEIN KINASE; THYMIDINE DERIVATIVE; 1,3 BUTADIENE DERIVATIVE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DNA; ENZYME INHIBITOR; FLAVONOID; GROWTH INHIBITOR; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NITRILE; ORGANOARSENIC DERIVATIVE; OXIDE; PYRIDINE DERIVATIVE; THYMIDINE;

ADJUVANT CHEMOTHERAPY; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; STAINING; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; TISSUE CULTURE TECHNIQUE; WESTERN BLOTTING;

APOPTOSIS; ARSENICALS; BLOTTING, WESTERN; BUTADIENES; CELL SURVIVAL; DNA; ENZYME INHIBITORS; FLAVONOIDS; GROWTH INHIBITORS; HUMANS; IMIDAZOLES; MAP KINASE KINASE 1; NITRILES; OXIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; THYMIDINE; TISSUE CULTURE TECHNIQUES; TUMOR CELLS, CULTURED;

EID: 33644980607     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04302.x     Document Type: Article

References (37)

1. Temp. (Grant No.2002CB512900
2. Tallman MS. Acute promyelocytic leukemia as a paradigm for targeted therapy. Semin. Hematol. 2004 41 ( Suppl. 4 27 32.
3. Liu P Han ZC. Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide. Review of clinical and basic studies. Int. J. Hematol. 2003 78 : 32 9.
4. Douer D. Advances in the treatment of relapsed acute promyelocytic leukemia. Acta Haematol. 2002 107 : 1 17.
5. Tallman MS Nabhan C Feusner JH Rowe JM. Acute promyelocytic leukemia: Evolving therapeutic strategies. Blood 2002 99 : 759 67.
6. 3 exerts dose-dependent dual effects on APL cells. Blood 1997 89 : 3345 53.
7. Kang YH Yi MJ Kim MJ et al. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: Reactive oxygen species-mediated poly (ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 2004 64 : 8960 7.
8. Jiang TT Brown SL Kim JH. Combined effect of arsenic trioxide and sulindac sulfide in A549 human lung cancer cells in vitro. J. Exp Clin. Cancer Res. 2004 23 : 259 62.
9. Kanzawa T Kondo Y Ito H Kondo S Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 2003 63 : 2103 8.
10. Miller Jr WH. Molecular targets of arsenic trioxide in malignant cells. Oncologist 2002 7 ( Suppl. 1 14 19.
11. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 2001 61 : 5432 40.
12. Baj G Arnulfo A Deaglio S et al. Arsenic trioxide and breast cancer. Analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res. Treat. 2002 73 : 61 73.
13. Johnson GL Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002 298 : 1911 12.
14. Davison K Mann KK Waxman S Miller Jr WH. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells. Blood 2004 103 : 3496 502.
15. Kajiguchi T Yamamoto K Hossain K et al. Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1. Leukemia 2003 17 : 2189 95.
16. Kang SH Song JH Kang HK et al. Arsenic trioxide-induced apoptosis is independent of stress-responsive signaling pathways but sensitive to inhibition of inducible nitric oxide synthase in HepG2 cells. Exp. Mol. Med. 2003 35 : 83 90.
17. 2+-dependent production of superoxide. Int. J. Cancer 2001 92 : 518 26.
18. Verma A Mohindru M Deb DK et al. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide. J. Biol. Chem. 2002 277 : 44 88 95.
19. Fernandez C Ramos AM Sancho P Amran D de Blas E Aller P. 12-O-Tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione. J. Biol. Chem. 2004 279 : 3877 84.
20. Scholz C Wieder T Starck L et al. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Oncogene 2005 24 : 1904 13.
21. Lunghi1 P Tabilio A Lo-Coco F Pelicci P Bonati A. Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells. Leukemia 2005 19 : 234 44.
22. Kanzawa T Zhang L Xiao L Germano IM Kondo Y Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondria cell death protein BNIP3. Oncogene 2005 24 : 980 91.
23. Jiang XH Wong BC Yuen ST et al. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int. J. Cancer 2001 91 : 173 9.
24. Yih LH Lee TC. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res. 2000 60 : 6346 52.
25. Chen NY Ma WY Huang C Ding M Dong Z. Activation of PKC is required for arsenite-induced signal transduction. J. Environ. Pathol. Toxicol. Oncol. 2000 19 : 297 305.
26. Kitamura K Minami Y Yamamoto K et al. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 2000 14 : 1743 50.
27. Chou WC Hawkins AL Barrett JF Griffin CA Dang CV. Arsenic inhibition of telomerase transcription leads to genetic instability. Arsenic inhibition of telomerase transcription leads to genetic instability. J. Clin. Invest. 2001 108 : 1541 7.
28. Shen ZY Shen J Cai WJ Hong C Zheng MH. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. Int. J. Mol. Med. 2000 5 : 155 8.
29. Ahmad S Kitchin KT Cullen WR. Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 2000 382 : 195 202.
30. Shim MJ Kim HJ Yang SJ Lee IS Choi HI Kim T. Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells. Possible involvement of p38 MAP kinase. J. Biochem. Mol. Biol. 2002 35 : 377 83.
31. Aguirre-Ghiso JA Estrada Y Liu D Ossowski L. ERK (MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38 (SAPK). Cancer Res. 2003 63 : 1684 95.
32. Mueller H Flury N Eppenberger-Castori S Kueng W David F Eppenberger U. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients. Int. J. Cancer 2000 89 : 384 8.
33. Xia Z Dickens M Raingeaud J Davis RJ Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995 270 : 1326 31.
34. Jarpe MB Widmann C Knall C et al. Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to death. Oncogene 1998 17 : 1475 82.
35. Bonni A Brunet A West AE Datta SR Takasu MA Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999 286 : 1358 62.
36. Dent P Grant S. Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase/mitogen-activated protein kinase signal transduction pathway: Potential role in promoting cytotoxic drug action. Clin. Cancer Res. 2001 7 : 775 83.
37. Romerio F Zella D. MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J. 2002 16 : 1680 2.